Clinical trial for Trichotillomania
Official title Technology Assisted Treatment of Trichotillomania: Open Trial
ClinicalTrials.gov ID: NCT07224126
What this study is testing
- What it's testing
- The study wants to see if the bracelet is easy to use and whether it can lower self‑reported hair‑pulling severity and increase awareness of the behavior.
- Who it's for
- Adults who have trichotillomania (hair‑pulling disorder).
- What's involved
- Participants will wear the Keen2 bracelet for eight weeks. For the first four weeks they will log their emotions, location, and activity after each detected pulling episode, then receive personalized alerts to guide coping strategies.
- Time commitment
- The trial lasts eight weeks, during which participants wear the device continuously and complete daily logging and alerts.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- 18 years of age (criterion 1a) with a diagnosis of TTM (criterion 1b)
- Must reportEnglish as their primary language (criterion 2)
- Report no current pharmacological or psychosocial intervention targeting TTM symptoms OR a6-week course of either intervention modality without...
- Reliable and consistent access to the internet and/or mobile device permitting the participant to meet withsomeone virtually for 90 min.
- Must report owning/access to a mobilephone running on Apple's operating system (iOS)
You likely can't join if
- Current suicidal/homicidal ideation, intent, or plan
- a diagnosis of another psychiatric condition that may impeded a participant's ability to fully utilize the app (e.g., psychotic disorder, major...
See the full eligibility criteria
- 18 years of age (criterion 1a) with a diagnosis of TTM (criterion 1b)
- Must reportEnglish as their primary language (criterion 2)
- Report no current pharmacological or psychosocial intervention targeting TTM symptoms OR a6-week course of either intervention modality without change in frequency,intensity, or dosage (criterion 3)
- Reliable and consistent access to the internet and/or mobile device permitting the participant to meet withsomeone virtually for 90 min.
- Must report owning/access to a mobilephone running on Apple's operating system (iOS)
- Identifies a support person that is able to be contacted is an emergency arises.
- Agrees to allow the Kent State research team to share home address, mobile number, andalternate number/email with HabitAware, Inc., for purposes of mailing Keen2device and setting up Keen2 system.
- Current suicidal/homicidal ideation, intent, or plan
- a diagnosis of another psychiatric condition that may impeded a participant's ability to fully utilize the app (e.g., psychotic disorder, major depressive disorder)
The study team makes the final eligibility decision.
Where it is enrolling
- Kent, Ohio, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Kent, Ohio, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.